Fabian Gerlinghaus is the Co-Founder and Chief Executive Officer of Cellares, a biotechnology company pioneering advancements in cell therapy manufacturing. With over a decade of experience as an innovator and leader, he has consistently assembled high-performing teams to drive novel bioprocessing technologies from concept to commercial readiness. Before founding Cellares, Gerlinghaus served as Chief Innovation Officer at Synthego, where he co-invented the company's proprietary RNA synthesizer technology and played a pivotal role in expanding the company from five to over 230 employees.